Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure
- 1 September 2000
- journal article
- research article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 6 (3) , 201-207
- https://doi.org/10.1054/jcaf.2000.8833
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activationEuropean Journal of Clinical Investigation, 1998
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- Metabolic, functional, and haemodynamic staging for CHF?The Lancet, 1996
- Inhibition of myocardial endothelin pathway improves long-term survival in heart failureNature, 1996
- New Insights Into the Cardiac Natriuretic PeptidesCirculation, 1996
- Myocardial EndothelinCirculation, 1996
- Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failureThe Lancet, 1995
- Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: Effect of captoprilJournal of the American College of Cardiology, 1994
- Elevated endothelin-1 in heart failure and loss of normal response to postural change.Circulation, 1992
- Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).Circulation, 1990